Investors are upset, and they should be. Policymakers seem determined to sit on their hands while economies either stagnate or deterioate around the globe. In this video, analyst David Williamson discusses why the markets are reacting poorly after inaction from the Federal Reserve and the European Central Bank. He also looks at stocks that are selling off even worse. One is another finance company that may be tanked by a poor trade (but fortunately it isn't too big to fail), and David looks at a pair of biotechs dealing with FDA rejections and quarterly earnings.
Many investors are attracted to biotechs since they hold the allure of substantial short-term gains. But there is more than one approach to building long-term wealth and retiring well. In our free report, "3 Stocks That Will Help You Retire Rich," we reveal some stocks that could help you, as well as some winning wealth-building strategies. Click here to keep reading.
David Williamson holds no position in any company mentioned. Click here to see his holdings and a short bio. The Motley Fool owns shares of Oracle. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.